Healthcare / BiotechnologyUpdated 2026-05-10 22:07 UTC

TPE/1733 stock hub

TPE/1733 has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

TPE/1733is not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

2.8B

Taiwan Stock Exchange

Market data

Live price

Current market quote for this ticker.

Current price

TPE/1733

In the news

Latest news · TPE/1733

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/En/a

P25 12P50 15.5P75 22.5

Trailing P/E17.5

P25 14.4P50 18P75 31.9

ROE8.8

P25 -16.2P50 0.3P75 9.8

ROIC8.9

P25 -11.7P50 -0.2P75 8.8

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All TPE/1733 market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

238

Groups with data

Currency

TWD

Showing 238 of 238 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	Taiwan
Country code	TW
Enterprise value	TWD 2.3B
Exchange	Taiwan Stock Exchange
Financial currency	TWD
First seen	2026-05-10
Industry	Biotechnology
Isin	TW0001733004
Last refreshed	2026-05-10
Market cap	TWD 2.8B
Price	TWD 28.35
Price currency	TWD
Sector	Healthcare
Sic	2835
Symbol	tpe/1733
Website	https://www.apexbio.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	5.75%
EV Earnings	14.12x
EV/EBIT	16.34x
EV/EBITDA	11.47x
EV/FCF	15.88x
EV/Sales	1.18x
FCF yield	5.11%
P/B ratio	1.51x
P/E ratio	17.5x
P/S ratio	1.46x
PE Ratio10 Y	57.35x
PE Ratio3 Y	23.41x
PE Ratio5 Y	20.04x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	7.24%
EBITDA Margin	9.82%
FCF margin	7.45%
Gross margin	27.7%
Gross Profit	TWD 538.7M
Gross Profit Growth	3.34%
Gross Profit Growth Q	-12.35%
Gross Profit Growth3 Y	-2.25%
Gross Profit Growth5 Y	3.56%
Net Income	TWD 162.9M
Net Income Growth	27.26%
Net Income Growth Q	30.09%
Net Income Growth Quarters	1%
Net Income Growth Years	2%
Net Income Growth3 Y	-3.59%
Net Income Growth5 Y	11.44%
Pretax Margin	9.76%
Profit Margin	8.38%
Profitable Years	17
ROA	3.64
Roa5y	3.96
ROCE	7.09
ROE	8.83
Roe5y	8.87
ROIC	8.95
Roic5y	9.92

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr10y	-0.18%
Cagr15y	-1.27%
Cagr1y	-1.2%
Cagr20y	5.51%
Cagr3y	4.35%
Cagr5y	7.57%
Div CAGR10	-7.08%
Div CAGR3	-2.63%
Div CAGR5	1.64%
EPS Growth	27.56
EPS Growth Q	31.41
EPS Growth Quarters	1
EPS Growth Years	2
EPS Growth3 Y	-3.63
EPS Growth5 Y	13.16
FCF Growth	-51.78%
FCF Growth Q	-43.8%
FCF Growth5 Y	-9.25%
OCF Growth	-51.28%
OCF Growth Q	-43.17%
OCF Growth10 Y	-10.25%
OCF Growth3 Y	81.87%
OCF Growth5 Y	-10.61%
Revenue Growth	5.01x
Revenue Growth Q	-3.3x
Revenue Growth Years	2x
Revenue Growth3 Y	-4.66x
Revenue Growth5 Y	-0.61x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	TWD 0.8
Assets	TWD 2.4B
Cash	TWD 644.4M
Current Assets	TWD 1.7B
Current Liabilities	TWD 432M
Debt	TWD 109.7M
Debt EBITDA	TWD 0.55
Debt Equity	TWD 0.06
Debt FCF	TWD 0.76
Equity	TWD 1.9B
Interest Coverage	41.54
Liabilities	TWD 545.3M
Long Term Assets	TWD 742.2M
Long Term Liabilities	TWD 113.3M
Net Cash	TWD 534.7M
Net Cash By Market Cap	TWD 18.87
Net Cash Growth	12.37%
Net Debt EBITDA	TWD -2.8
Net Debt Equity	TWD -0.29
Net Debt FCF	TWD -3.69
Tangible Book Value	TWD 1.8B
Tangible Book Value Per Share	TWD 18.35
WACC	5.47

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	3.87
Inventory Turnover	2.3
Net Working Capital	TWD 604.9M
Quick ratio	2.53
Working Capital	TWD 1.2B
Working Capital Turnover	TWD 1.62

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-0.15%
Dividend Growth	9.09%
Dividend Growth Years	1%
Dividend per share	TWD 1.3
Dividend Years	23
Dividend Yield	4.59%
Ex Div Date	2025-06-11
Last Dividend	TWD 1.2
Payout Frequency	Annual
Payout Ratio	73.63%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
10Y total return	-1.75%
1Y total return	-1.19%
200-day SMA	30.56
3Y total return	13.61%
50-day SMA	29.34
50-day SMA vs 200-day SMA	50under200
5Y total return	44.03%
All Time High	98.7
All Time High Change	-71.28%
All Time High Date	2007-07-25
All Time Low	14.42
All Time Low Change	96.66%
All Time Low Date	2000-12-27
ATR	0.48
Beta	0.24
Beta1y	-0.01
Beta2y	0.19
Ch YTD	-6.9
High	28.5
High52	38.7
High52 Date	2025-10-21
High52ch	-26.74%
Low	28.05
Low52	27
Low52 Date	2025-07-23
Low52ch	5%
Ma50ch	-3.36%
Price vs 200-day SMA	-7.23%
RSI	38.29
RSI Monthly	45.07
RSI Weekly	39.8
Sharpe ratio	-0.41x
Sortino ratio	-0.37
Total Return	4.44%
Tr YTD	-6.9
Tr15y	-17.42%
Tr1m	-4.06%
Tr1w	0.18%
Tr3m	-5.97%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Operating Income	TWD 140.7M
Operating Income Growth	9.55
Operating Income Growth Q	-30.42
Operating Income Growth3 Y	-7.28
Operating Income Growth5 Y	6.37
Operating margin	7.24

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	66,362,500%
Net Borrowing	-8,715,000
Shares Insiders	10.69%
Shares Institutions	2.26%
Shares Out	99,950,192
Shares Qo Q	1.08%
Shares Yo Y	0.15%

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	TWD 144.9M
Average Volume	153,521.9x
Bv Per Share	18.71
CAPEX	TWD -15.3M
Ch10y	-35.93
Ch15y	-59.73
Ch1m	-4.06
Ch1w	0.18
Ch1y	-5.03
Ch20y	12.79
Ch3m	-5.97
Ch3y	0.71
Ch5y	15.95
Ch6m	-10.99
Change	0.35%
Change From Open	0.18
Close	28.25
Days Gap	0.18
Depreciation Amortization	50,198,000
Dollar Volume	3,612,839
Earnings Date	2026-03-27
EBIT	TWD 140.7M
EBITDA	TWD 190.9M
EPS	TWD 1.62
F Score	5
FCF	TWD 144.9M
FCF EV Yield	6.3x
FCF Per Share	TWD 1.45
Financing CF	-128,655,000
Fiscal Year End	December
Founded	1,997
Graham Number	26.11228
Graham Upside	-7.89
Income Tax	TWD 26.9M
Investing CF	-5,543,000
Is Primary Listing	1
Last Earnings Date	2025-11-10
Last Report Date	2025-12-31
Last Split Date	2009-07-01
Last Split Type	Forward
Lynch Fair Value	TWD 18.53
Lynch Upside	-34.66
Ma150	30.94
Ma150ch	-8.38%
Ma20	29.03
Ma20ch	-2.34%
Net CF	34,406,000
Open	28.3
P FCF Ratio	19.56
P OCF Ratio	17.7
Payment Date	2025-07-08
Position In Range	66.67
Ppne	652,643,000
Price Date	2026-05-08
Price EBITDA	TWD 14.84
Ptbv Ratio	1.55
Relative Volume	0.83x
Revenue	1,944,907,000x
Tax By Revenue	1.38x
Tax Rate	14.14%
Tr20y	192.06%
Tr6m	-10.99%
Volume	127,437
Z Score	5.48

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

TPE/1733 dividend yield, growth & safety

Yield, payout sustainability, and the multi-year growth streak.

Dividend yield

+4.6%

$1.30 annual per share

Payout ratio

+73.6%

Share of earnings returned as dividends. Below 60% is generally sustainable.

5Y dividend CAGR

+1.6%

1 consecutive years of growth

Total shareholder yield

+4.4%

Next ex-dividend date: 2025-06-11

Performance

TPE/1733 stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns TPE/1733?

Insider, institutional, and short-interest positioning.

Institutional ownership

+2.3%

Share of float held by funds and institutions

Insider ownership

+10.7%

Stake held by company insiders. Higher generally signals alignment.

Short interest

n/a

Float sold short by bearish positioning

Y/Y dilution

+0.1%

Negative means the company is buying back shares.

Technical

TPE/1733 momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

38.3

Neutral momentum band

Price vs 200-day MA

-7.2%

50/200-day relationship not available

Beta (5Y)

0.24

Less volatile than the market

Sharpe ratio

-0.41

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About TPE/1733

Hub-level FAQ points readers to the deeper analysis pages.

What is the current tpe/1733 stock rating?

tpe/1733 is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full tpe/1733 analysis?

The full report lives at /stocks/tpe/1733/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for tpe/1733?

The latest report frames tpe/1733 around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the tpe/1733 page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.